• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    More On ONCY

    Oncolytics Biotech Inc. (ONCY)

    -NasdaqCM
    1.16 Up 0.09(8.41%) Mar 3, 4:00PM EST
    |Pre-Market : 1.17 7:52PM EST
    Add to Portfolio
    Prev Close:1.07
    Open:1.27
    Bid:1.13 x 600
    Ask:1.14 x 200
    1y Target Est:3.81
    Beta:2.03
    Next Earnings Date:N/A
    Day's Range:1.12 - 1.40
    52wk Range:0.40 - 2.07
    Volume:34,091,907
    Avg Vol (3m):1,620,530
    Market Cap:104.91M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ONCY

    Comparison

    Symbol% ChgMkt Cap
    ONCYUp 8.41%104.91M
    GSKDown 0.46%114.77B
    INFI 0.00%780.76M
    MDVNUp 0.27%9.50B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.26
    Quarterly EPS Est (Dec-14) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback